H.I.G. BioHealth Partners

H.I.G. BioHealth Partners

Signal active

Investment Firm

Overview

H.I.G. BioVentures invests in a broad range of life science companies across multiple sectors and stages of development. Their seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical devices, diagnostics, basic science, clinical research, and technology transfer. They invest in companies developing novel products for significant unmet medical needs.

Highlights

Founded

2011

Industry

Venture Capital

Employees

501-1000

Investment

26

Lead Investment

12

Exits

7

Stages

Early Stage Venture, Late Stage Venture

Investor Type

Venture Capital

Location

United States, North America

Contact Information

Social

Profile Resume

H.I.G. BioHealth Partners, established in 2011 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture investments across Health Care, Manufacturing, Medical Device, Finance, Asset Management, Wealth Management, Venture Capital, Banking, Non Profit, Pharmaceutical. The organization boasts a portfolio of 26 investments, with an average round size of $31.4M and 7 successful exits. Their recent investments include NeuWave Medical, State of Wisconsin Investment Board, Venture Investors, Wisconsin Alumni Research Foundation, Intact Vascular. The highest investment round they participated in was $56.3B. Among their most notable exits are NeuWave Medical and State of Wisconsin Investment Board. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Sami Mnaymneh

Sami Mnaymneh

Co-Founder, Executive Chairman, CEO

imagePlace Tony Tamer

Tony Tamer

Co-Founder & Executive Chairman

imagePlace Bruce Robertson

Bruce Robertson

Managing Director

Investment portfolio

H.I.G. BioHealth Partners has made 26 investments. Their most recent investment was on Oct 22, 2021, when Click Therapeutics raised $52.0M.

H.I.G. BioHealth Partners has made 3 diversity investments. Their most recent diversity investment was on Jul 16, 2019, when Exagen raised $22.6M.

investments

26

Diversity investments

3

Lead investments

12

Number of exits

7

Investments

26

Annouced DateOrganization NameIndustryMoney Raised
Jul 16, 2019
Exagen Exagen
Biotechnology22.6M
Oct 23, 2019
Zerigo Health Zerigo Health
Biotechnology18.0M
May 27, 2020
Arvelle Therapeutics Arvelle Therapeutics
Biotechnology42.7M
Oct 22, 2021
Click Therapeutics Click Therapeutics
Biotechnology52.0M

Exits

7

Funding Timeline

Funding rounds

26

Investors

0

Funds

1

Funding Rounds

26

H.I.G. BioHealth Partners has raised 26 rounds. Their latest funding was raised on Oct 22, 2021 from a Series B - Click Therapeutics round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Jul 16, 2019
Venture Round - Exagen Venture Round - Exagen
-22.6M-
Oct 23, 2019
Series A - Zerigo Health Series A - Zerigo Health
-18.0M-
May 27, 2020
Series A - Arvelle Therapeutics Series A - Arvelle Therapeutics
-42.7M-
Oct 22, 2021
Series B - Click Therapeutics Series B - Click Therapeutics
-52.0M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.